Showing posts with label evolution. Show all posts
Showing posts with label evolution. Show all posts

Wednesday, March 2, 2011

Of sex and death



Why does sex exist? And why having sex with another organism instead of oneself? These are two of the questions that Patrick Phillips, from the Unviersity of Oregon, tried to answer in his talk at the PRBB last week.

The biologist uses the nematode C.elegans for his research, which consists primarily in recreating evolution in the lab. How does that work? It basically consists of two steps: artificial selection+adaptation to the laboratory conditions. That is, he creates a novel environment, generates mutations in the worms, and sees which ones adapt and which ones die. Cruel? Not more than reality…

The advantages of these evolutionary experiments in the lab is that they are controlled and can be replicated. The problems are that they are limited in time (while real evolution takes 1000s of years) and there’s also a limited population size, which means that rare events (as in rare mutations) won’t be seen. Regardless of these inconveniences, Phillips managed to convince the audience that these experiments can prove that sex is good – to get rid of deleterious mutations and to increase genetic variation, which provides a better adaptation to the changing environment.

According to the scientist, one reason C. elegans is good for studying evolution is that they can be frozen. When you are doing the kind of experiments he does, if you freeze worms from different generations along the experiment, you have the equivalent to a ‘fossil register’ that allows you to compare the organisms at the ‘beginning’ and the ‘end’ of the evolution phase you are studying. Isn´t that cool?

Apart from sex, Phillips also talked about death – or why we age. Again, the elegans nematode plays an important role in ageing research: actually some mutants can live up to 10 times their usual lifespan. That is the equivalent of a human living 1000 years!

His experiment consisted in breading the worms for 323 generations by selecting only one worm in each generation to spread the population. As a consequence, the population size went dooooown and the worms were very sick (ah, the lack of genetic variation!). He then, playing God, saved the species by letting a higher number of worms reproduce for another 60 generations. When he compared the genome of the sick (thanks to his ‘fossil record’) and the recovered worms he found very few changes: only about 10 nucleotides! He went back in history to check when each change had taken place – again, thanks to the frozen worms (amazing, eh?). What he found is that the ‘recovery’ mutations were not the result of ‘mutating back’ to the original sequence, but rather they were compensatory mutations.

All in all, he showed us what he called an ‘emerging paradigm in evolutionary biology’, a new way of studying evolution: create a perturbation (mutation); propagate the species for 50-100 generations to let them recover fitness; sequence the genome to find out which changes have occurred; use genetics to confirm the results.

Voilà! Now you can try it at home :)

Monday, December 21, 2009

The major scientific discovery of the year according to PRBB researchers

Every year there are hundreds of new scientific discoveries made in the world, many of them small steps, others bigger. Now that we reach the end of 2009, I have asked researchers of the different centres at the PRBB what has been, in their view, the most exciting scientific advance in their field. Their replies (below) were published in the 29th issue of El·lipse.

 PROTEOMICS
Toni Pascual (IMIM-Hospital del Mar)
“Christian Reichel from the Austrian Research Centre and a proteomics and doping researcher, has discovered that the SDS universally used in SDS-PAGE to separate proteins by their molecular weight, also binds to polymers such as polyethylene glycols, modifying their migration and making their recognition by antibodies more difficult. The use of sarcosyl instead of SDS avoids this problem. This finding is very relevant given the very frequent presence of these polymers in recombinant drugs”




HUMAN GENETICS
Ben Lehner (CRG)
“Over the past year there has been a bit of a revolution in human genetics, and many variants have been discovered in the genome that influence the risk of common diseases such as cancer. The identity of these variants has the potential to tell us about the biology of such diseases, but in nearly all cases they only have a tiny overall effect on disease. This tells us that we still do not understand the genetics of complex diseases and traits - for example why tall parents have tall children. It's rather humbling considering the amount of money that has been spent.”



EVOLUTION
Arcadi Navarro (CEXS-UPF)
“One of the most remarkable discoveries of the year has been the description of a new hominid species, Ardipithecus ramidus. The discovery has everything: it gives us information about a part of our phylogeny that is very close to our common ancestor with chimpanzees and of which we had few fossils so far; confirms once more that Darwin was right; and it has been the subject of the usual media manipulation by the creationists. In Al-Jazeera they have showed a documentary in which they explain that “Ardi” “demonstrates” that the man does not come from the monkey. Spectacular!”


STEM CELLS
Núria Montserrat (CMRB)
"The reprogramming of umbilical cord cells has been one of the major advances this year, since it opens the door to the future cell therapy. These cells, because they are so young, have not had time to accumulate possible mutations and they are immunologically immature, which minimises the risk of rejection. Also, they can be reprogrammed in a short period of time and without the need to overexpress the oncogenes that so far have been used. All this makes me think they might be an optimal source for future studies in cell therapy and regenerative medicine”.


EPIDEMIOLOGY
Jordi Sunyer (CREAL)
“Peter Gluckman, from the University of Auckland, has demonstrated how environmental influences during mammalian development lead to stable changes in the epigenome that alter the individual's susceptibility to chronic metabolic and cardiovascular disease, acceleration of pubertal timing or impaired cognitive development. Overall, it provides a model for how early life offers a potential point for preventative intervention.”